» Articles » PMID: 37133558

The Comparative Effectiveness of Metformin and Risperidone in a Rat Model of Valproic Acid-induced Autism, Potential Role for Enhanced Autophagy

Overview
Specialty Pharmacology
Date 2023 May 3
PMID 37133558
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Risperidone is the first antipsychotic to be approved by Food and Drug Administration (FDA) for treating autism spectrum disorder (ASD). The potential efficacy of metformin in preventing and/or controlling ASD behavioral deficits was also recently reported. Suppression of hippocampus autophagy was suggested as a potential pathologic mechanism in ASD.

Objectives: Is metformin's ability to improve ASD clinical phenotype driven by its autophagy-enhancing properties? And does hippocampus autophagy enhancement underlie risperidone's efficacy as well? Both questions are yet to be answered.

Methods: The effectiveness of metformin on alleviation of ASD-like behavioral deficits in adolescent rats exposed prenatally to valproic acid (VPA) was compared to that of risperidone. The potential modulatory effects of risperidone on hippocampal autophagic activity were also assessed and compared to those of metformin.

Results: Male offspring exposed to VPA during gestation exhibited marked anxiety, social impairment and aggravation of stereotyped grooming; such deficits were efficiently rescued by postnatal risperidone or metformin therapy. This autistic phenotype was associated with suppressed hippocampal autophagy; as evidenced by reduced gene/dendritic protein expression of LC3B (microtubule-associated proteins 1 light chain 3B) and increased somatic P62 (Sequestosome 1) protein aggregates. Interestingly, compared to risperidone, the effectiveness of metformin in controlling ASD symptoms and improving hippocampal neuronal survival was well correlated to its ability to markedly induce pyramidal neuronal LC3B expression while lowering P62 accumulation.

Conclusions: Our work highlights, for the first time, positive modulation of hippocampus autophagy as potential mechanism underlying improvements in autistic behaviors, observed with metformin, as well as risperidone, therapy.

Citing Articles

Developmental deficits, synapse and dendritic abnormalities in a Clcn4 KO autism mice model: endophenotypic target for ASD.

Lee S, Choi Y, Kim D, Jeong H, Do Y, Jung S Transl Psychiatry. 2025; 15(1):28.

PMID: 39863599 PMC: 11762770. DOI: 10.1038/s41398-024-03201-6.


Comparative effect of atorvastatin and risperidone on modulation of TLR4/NF-κB/NOX-2 in a rat model of valproic acid-induced autism.

Farrag E, Askar M, Abdallah Z, Mahmoud S, Abdulhai E, Abdelrazik E Behav Brain Funct. 2024; 20(1):26.

PMID: 39350139 PMC: 11742802. DOI: 10.1186/s12993-024-00250-1.

References
1.
Arnoux I, Willam M, Griesche N, Krummeich J, Watari H, Offermann N . Metformin reverses early cortical network dysfunction and behavior changes in Huntington's disease. Elife. 2018; 7. PMC: 6156080. DOI: 10.7554/eLife.38744. View

2.
Tartaglione A, Schiavi S, Calamandrei G, Trezza V . Prenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorder. Neuropharmacology. 2019; 159:107477. DOI: 10.1016/j.neuropharm.2018.12.024. View

3.
Paval D, Rad F, Rusu R, Niculae A, Colosi H, Dobrescu I . Low Retinal Dehydrogenase 1 (RALDH1) Level in Prepubertal Boys with Autism Spectrum Disorder: A Possible Link to Dopamine Dysfunction?. Clin Psychopharmacol Neurosci. 2017; 15(3):229-236. PMC: 5565080. DOI: 10.9758/cpn.2017.15.3.229. View

4.
Liu D, Nanclares C, Simbriger K, Fang K, Lorsung E, Le N . Autistic-like behavior and cerebellar dysfunction in Bmal1 mutant mice ameliorated by mTORC1 inhibition. Mol Psychiatry. 2022; 28(9):3727-3738. PMC: 9481983. DOI: 10.1038/s41380-022-01499-6. View

5.
Wang L, Cai Y, Fan X . Metformin Administration During Early Postnatal Life Rescues Autistic-Like Behaviors in the BTBR T+ Itpr3tf/J Mouse Model of Autism. Front Behav Neurosci. 2018; 12:290. PMC: 6281763. DOI: 10.3389/fnbeh.2018.00290. View